Extensive troponin I and T modification detected serum from patients with acute myocardial infarction

Circulation

Volumn 102, Issue 11, 2000, Pages 1221-1226

  Labugger, Ralf ^a,b   Organ, Lenny ^a   Collier, Christine ^a   Atar, Dan ^c   Van Eyk, Jennifer E ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Rigshospitalet   (Denmark)

Author keywords

Biological markers; Blotting, western; Diagnosis; Myocardial infarction; Troponin

Indexed keywords

TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STANDARDIZATION;

EID: 0034641649     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.11.1221     Document Type: Article

References (24)

1. Cardiac troponin I and troponin T: Recent players in the field of myocardial markers
2. A comparison of cardiac troponin T and cardiac troponin I in patients with acute coronary syndromes
3. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
4. Diagnostic efficiency of troponin T measurements in acute myocardial infarction
5. The prognostic value of serum troponin T in unstable angina
6. Markers of myocardial injury in blood following PTCA: A comparison of CKMB, cardiospecific troponin T and troponin I
7. New approach to standardisation of human cardiac troponin I (cTnI)
8. The lack of standardization of cardiac troponin I assay systems
9. Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I
10. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays
11. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I: American Association for Clinical Chemistry Subcommittee on cTnI Standardization
12. Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia
13. Degradation of human cardiac troponin I after myocardial infarction
14. Role of troponin I proteolysis in the pathogenesis of myocardial stunning
15. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury
16. Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: Identification of degradation products and effects on the pCa-force relation
17. Transgenic mouse model of stunned myocardium
18. Biochemistry in the OR: TnI Modification in bypass surgery
19. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB
20. Selective dephosphorylation of proteins containing phosphotyrosine by alkaline phosphatases
21. Protein (serine, and threonine) phosphate phosphatases
22. Clinical and analytical standardization issues confronting cardiac troponin I
23. Clinical efficacy assays for cardiac troponin I for risk stratification in acute coronary syndromes: A thrombolysis in myocardial infarction (TIMI) IIB substudy
24. Degradation of cardiac troponin I: Implication for reliable immunodetection